Breaking News

Chiltern Acquires Pacific Clinical Research

Expands therapeutic offerings and Asia-Pac reach

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The acquisition allows Chiltern to offer services throughout the Asia-Pacific region and expands its oncology and anti-infective offerings. The combined company adds direct capabilities in Hong Kong, Korea, Malaysia, Philippines and Thailand, expanding Chiltern’s existing operations in India, Australia, Singapore and Taiwan.   Pacific Clinical Research founders Robert Teoh MD and Vonny Iskandar will serve ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters